Holen Sie sich die Stockscreener-App
0.6776
4.29%
0.0266
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
22.61%
6.98
|
9.019 | 7.468 | 7.793 | 7.098 |
| Operating Income/Loss |
22.61%
-6.98
|
-9.019 | -7.468 | -7.793 | -7.098 |
| Income/Loss From Continuing Operations Before Tax |
24.19%
-5.878
|
-7.754 | -6.229 | -9.83 | -6.281 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
24.19%
-5.878
|
-7.754 | -6.229 | -9.83 | -6.281 |
|
Net Income/Loss
|
24.19%
-5.878
|
-7.754 | -6.229 | -9.83 | -6.281 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
47,859%
125.32
|
-0.2624 | 125.79 | 126.62 | 126.62 |
| Diluted Average Shares |
125.32
|
- | - | - | - |
| Basic Earnings Per Share |
16.67%
-0.05
|
-0.06 | -0.05 | -0.08 | -0.05 |
| Diluted Earnings Per Share |
-0.05
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.21%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):